SCHEMBL254089

SCHEMBL254089

COC[C@@H](OCCO)n1ccc(=O)[nH]c1=O

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.45
HSD17B10 Q99714 1/20 0.45
PKM P14618 1/20 0.40
ALDH1A1 P00352 2/20 0.38
LMNA P02545 1/20 0.38
CRBN Q96SW2 2/20 0.37
DUT P33316 9/20 0.36
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
KMT2A Q03164 1/20 0.32
SLC28A1 O00337 1/20 0.32
SLC28A2 O43868 1/20 0.32
SLC29A1 Q99808 1/20 0.32
SLC28A3 Q9HAS3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25701041 0.89 PKM (0.42) POLBHSD17B10PKMCRBNDUT
SCHEMBL21318352 0.85 PKM (0.43) POLBHSD17B10PKMALDH1A1LMNA
SCHEMBL14389711 0.81 PKM (0.43) POLBHSD17B10PKMALDH1A1LMNA
SCHEMBL11102286 0.81 PKM (0.43) POLBHSD17B10PKMALDH1A1LMNA
SCHEMBL25611388 0.80 POLB (0.61) POLBHSD17B10PKMALDH1A1LMNA
SCHEMBL21935625 0.80 POLB (0.67) POLBHSD17B10PKMALDH1A1LMNA
SCHEMBL25605484 0.79 POLB (0.55) POLBHSD17B10PKMALDH1A1LMNA
SCHEMBL25605487 0.79 POLB (0.55) POLBHSD17B10PKMALDH1A1LMNA
SCHEMBL15216128 0.78 PKM (0.39) POLBHSD17B10PKMALDH1A1LMNA
SCHEMBL16579294 0.78 POLB (0.41) POLBHSD17B10PKMALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014127378-A2 DESIGN OF SHORT OLIGONUCLEOTIDES AS VACCINE ADJUVANTS AND THERAPEUTIC AGENTS SPRING BANK PHARMACEUTICALS, INC. (US) 2014-08-21 WO disclosed
WO-2012030626-A2 DESIGN OF OLIGONUCLEOTIDE ANALOGS AS THERAPEUTIC AGENTS SPRING BANK PHARMACEUTICALS, INC. (US) 2012-03-08 WO disclosed